Cytek Biosciences, Inc. · NASDAQ:CTKB
Topline Capital Management, LLC reported a 5.30% stake in Cytek Biosciences, Inc. (Schedule 13G)
Event Sep 25, 2025 · Filed Nov 17, 2025
Topline Capital Management, LLC reported a 5.30% stake in Cytek Biosciences, Inc., 6,780,847 shares, as a passive investor on Sep 25, 2025. Filed Nov 17, 2025 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 6,780,847
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Topline Capital Management, LLC | 5.30% | 6,780,847 |
| Collin McBirney | 5.30% | 6,780,847 |
| Topline Capital Partners, LP | 5.30% | 6,780,847 |